688 related articles for article (PubMed ID: 29029794)
1. Rho-kinase inhibition reverses impaired Ca
Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mevalonate pathway prevents ischemia-induced cardiac dysfunction in rats via RhoA-independent signaling pathway.
Yang Y; Rong X; Lv X; Jiang W; Yang Y; Lai D; Xu S; Fu G
Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28665545
[TBL] [Abstract][Full Text] [Related]
3. Early testosterone replacement attenuates intracellular calcium dyshomeostasis in the heart of testosterone-deprived male rats.
Weerateerangkul P; Shinlapawittayatorn K; Palee S; Apaijai N; Chattipakorn SC; Chattipakorn N
Cell Calcium; 2017 Nov; 67():22-30. PubMed ID: 29029787
[TBL] [Abstract][Full Text] [Related]
4. Ellagic Acid Prevents Ca
Yamasan BE; Mercan T; Erkan O; Ozdemir S
Cardiovasc Toxicol; 2021 Aug; 21(8):630-641. PubMed ID: 33909254
[TBL] [Abstract][Full Text] [Related]
5. Orai1 Channel Inhibition Preserves Left Ventricular Systolic Function and Normal Ca
Bartoli F; Bailey MA; Rode B; Mateo P; Antigny F; Bedouet K; Gerbaud P; Gosain R; Plante J; Norman K; Gomez S; Lefebvre F; Rucker-Martin C; Ainscough JFX; Kearney MT; Bruns AF; Shi J; Appleby HL; Young RS; Shawer HM; Debant M; Gomez AM; Beech DJ; Foster R; Benitah JP; Sabourin J
Circulation; 2020 Jan; 141(3):199-216. PubMed ID: 31906693
[TBL] [Abstract][Full Text] [Related]
6. [The expression of Rho/Rho kinase of cardiac muscle in heart failure rats caused by pressure overload and the intervention of fasudil].
Zhang M; Qu C; Zeng DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):73-6. PubMed ID: 15924788
[TBL] [Abstract][Full Text] [Related]
7. Shen'ge powder decreases the cardiomyocyte hypertrophy in chronic heart failure by activating the Rho protein/Rho-associated coiledcoil forming protein kinase signaling pathway.
Yan X; Jiao K; Song X
J Cell Biochem; 2019 Mar; 120(3):3038-3045. PubMed ID: 30474257
[TBL] [Abstract][Full Text] [Related]
8. Early calcium handling imbalance in pressure overload-induced heart failure with nearly normal left ventricular ejection fraction.
Rouhana S; Farah C; Roy J; Finan A; Rodrigues de Araujo G; Bideaux P; Scheuermann V; Saliba Y; Reboul C; Cazorla O; Aimond F; Richard S; Thireau J; Fares N
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):230-242. PubMed ID: 30463691
[TBL] [Abstract][Full Text] [Related]
9. High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca(2+) leak through TLR4-ROS signaling in cardiomyocytes.
Zhang C; Mo M; Ding W; Liu W; Yan D; Deng J; Luo X; Liu J
J Mol Cell Cardiol; 2014 Sep; 74():260-73. PubMed ID: 24937603
[TBL] [Abstract][Full Text] [Related]
10. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
Li Q; Xu Y; Li X; Guo Y; Liu G
Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin converting enzyme inhibitor on the calcium transients and calcium handling proteins in ventricular myocytes from rats with heart failure.
Wang LC; Ma H; He JG; Liao XX; Chen WF; Leng XY; Ma L; Mai WY; Tao J; Zeng WT; Liu J; Dong YG; Tang AL; Feng C
Chin Med J (Engl); 2005 May; 118(9):731-7. PubMed ID: 15899134
[TBL] [Abstract][Full Text] [Related]
13. Ca
Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
[TBL] [Abstract][Full Text] [Related]
14. Low-dose combination of Rho kinase and L-type Ca(2+) channel antagonists for selective inhibition of depolarization-induced sustained arterial contraction.
Porras-González C; González-Rodríguez P; Calderón-Sánchez E; López-Barneo J; Ureña J
Eur J Pharmacol; 2014 Jun; 732():130-8. PubMed ID: 24680953
[TBL] [Abstract][Full Text] [Related]
15. CaMKIIδC Drives Early Adaptive Ca
Ljubojevic-Holzer S; Herren AW; Djalinac N; Voglhuber J; Morotti S; Holzer M; Wood BM; Abdellatif M; Matzer I; Sacherer M; Radulovic S; Wallner M; Ivanov M; Wagner S; Sossalla S; von Lewinski D; Pieske B; Brown JH; Sedej S; Bossuyt J; Bers DM
Circ Res; 2020 Oct; 127(9):1159-1178. PubMed ID: 32821022
[TBL] [Abstract][Full Text] [Related]
16. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
[TBL] [Abstract][Full Text] [Related]
17. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
Schwarz B; Percy E; Gao XM; Dart AM; Richardt G; Du XJ
Eur J Heart Fail; 2003 Mar; 5(2):131-6. PubMed ID: 12644002
[TBL] [Abstract][Full Text] [Related]
18. Nanoscale reorganization of sarcoplasmic reticulum in pressure-overload cardiac hypertrophy visualized by dSTORM.
Hadipour-Lakmehsari S; Driouchi A; Lee SH; Kuzmanov U; Callaghan NI; Heximer SP; Simmons CA; Yip CM; Gramolini AO
Sci Rep; 2019 May; 9(1):7867. PubMed ID: 31133706
[TBL] [Abstract][Full Text] [Related]
19. Cocaine activates calcium/calmodulin kinase II and causes cardiomyocyte hypertrophy.
Henning RJ; Cuevas J
J Cardiovasc Pharmacol; 2006 Jul; 48(1):802-13. PubMed ID: 16891908
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
